Weiping Xie Selected Research

N-vinyl-2-pyrrolidinone

8/2016	Characterization of the Uptake Efficiency and Cytotoxicity of Tetrandrine-Loaded Poly(N-vinylpyrrolidone)-Block-Poly(ε-caprolactone) (PVP-b-PCL) Nanoparticles in the A549 Lung Adenocarcinoma Cell Line.
1/2014	An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiping Xie Research Topics

Disease

13	Hypoxia (Hypoxemia) 01/2021 - 09/2004
9	Pulmonary Hypertension 07/2019 - 03/2005
8	Pulmonary Arterial Hypertension 01/2022 - 01/2015
8	Inflammation (Inflammations) 01/2022 - 09/2015
8	Vascular Remodeling 01/2020 - 09/2004
7	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2014
5	Neoplasms (Cancer) 10/2018 - 01/2014
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 04/2012
4	Right Ventricular Hypertrophy 01/2020 - 09/2004
3	Tuberculosis (Tuberculoses) 05/2022 - 06/2013
3	Fibrosis (Cirrhosis) 01/2021 - 01/2018
3	Hypertrophy 10/2018 - 06/2012
3	Adenocarcinoma of Lung 08/2016 - 09/2015
2	Acute Lung Injury 01/2019 - 01/2019
2	Hypersensitivity (Allergy) 01/2019 - 06/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2015 - 01/2014
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 09/2015 - 06/2015
1	Foreign Bodies (Foreign Body) 01/2022
1	Infections 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2020
1	Crohn Disease (Crohn's Disease) 08/2020
1	Autoimmune Diseases (Autoimmune Disease) 08/2020
1	Rheumatoid Arthritis 08/2020
1	COVID-19 01/2020

Drug/Important Bio-Agent (IBA)

8	MonocrotalineIBA 01/2022 - 01/2015
6	Proteins (Proteins, Gene)FDA Link 08/2020 - 03/2013
6	N- (1- methylethyl)- 1,1,2- trimethylpropylamineIBA 07/2019 - 09/2004
5	KATP ChannelsIBA 07/2019 - 09/2004
3	Pharmaceutical PreparationsIBA 04/2022 - 02/2008
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019 - 01/2018
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 01/2018
3	Adenosine Triphosphate (ATP)IBA 01/2019 - 03/2005
3	Nicorandil (SG 75)IBA 01/2019 - 03/2013
3	PotassiumIBA 01/2019 - 03/2005
3	InflammasomesIBA 01/2018 - 09/2015
2	Interleukin-2 (IL2)IBA 04/2022 - 06/2015
2	peoniflorinIBA 01/2022 - 01/2020
2	Etanercept (Enbrel)FDA Link 01/2021 - 06/2012
2	SaltsIBA 01/2021 - 01/2019
2	SmokeIBA 01/2021 - 06/2012
2	Therapeutic UsesIBA 01/2021 - 07/2019
2	Semaxinib (SU5416)IBA 01/2021 - 01/2020
2	fasudil (AT 877)IBA 01/2021 - 01/2019
2	InterleukinsIBA 08/2020 - 09/2015
2	CytokinesIBA 08/2020 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2015
2	CollagenIBA 01/2020 - 11/2012
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2019 - 03/2013
2	Liraglutide FDA Link 01/2019 - 01/2019
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 10/2018
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 01/2018
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2019 - 10/2018
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2019 - 01/2019
2	Becaplermin (PDGF-BB)FDA Link 01/2019 - 12/2016
2	Nanoparticle Drug Delivery SystemIBA 01/2019 - 08/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 06/2017
2	Caspase 3 (Caspase-3)IBA 12/2016 - 07/2013
2	caprolactoneIBA 08/2016 - 01/2014
2	N-vinyl-2-pyrrolidinoneIBA 08/2016 - 01/2014
2	tetrandrineIBA 08/2016 - 01/2014
2	Interleukin-18 (Interleukin 18)IBA 09/2015 - 09/2015
2	Oxygen (Dioxygen)IBA 04/2015 - 09/2004
1	RNA (Ribonucleic Acid)IBA 05/2022
1	Pyrazinamide FDA LinkGeneric 04/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2022
1	Isoniazid (Ftivazide)FDA LinkGeneric 04/2022
1	Ethambutol (Myambutol)FDA LinkGeneric 04/2022
1	PlasticsIBA 01/2022
1	Monoterpenes (Monoterpenoids)IBA 01/2022
1	GlycosidesIBA 01/2022
1	MetalsIBA 01/2022
1	GraphiteIBA 01/2022
1	CalciumIBA 01/2021
1	AntagomirsIBA 01/2021
1	Tigecycline (Tygacil)FDA Link 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Biotin (Vitamin H)FDA Link 01/2021
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	LactamsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	TransferasesIBA 01/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2021
1	rho-Associated KinasesIBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 08/2020
1	Carcinoembryonic AntigenIBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2020
1	cadherin 5IBA 01/2019
1	LipopolysaccharidesIBA 01/2019

Therapy/Procedure

3	Therapeutics 01/2021 - 03/2015
3	Drug Therapy (Chemotherapy) 05/2017 - 06/2015
1	Immunomodulation 01/2022
1	Subcutaneous Injections 01/2021